Cell to Cure ApS: Financial statements 2022
CVR: 39401975
Source: annual report 2022, Danish Business Authority
01/09/2021 – 31/08/2022
Cell to Cure ApS (CVR 39401975) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 389,024 and a net result of DKK -401,864 compared with DKK 217,939 the year before. That is an increase of 31.9% compared with the year before. Equity in the 2022 report amounted to DKK -365,549. The company had 5 employees in the financial year.
- Gross Profit
- DKK 389,024
- Profit/Loss
- DKK -401,864
- Equity
- DKK -365,549
- Total Assets
- DKK 1,487,121
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 389 t. | -402 t. | -366 t. | 5 |
| 2021 | - | 295 t. | 218 t. | 695 t. | 0 |
| 2020 | - | 523 t. | 405 t. | 462 t. | 0 |
Official annual report
Keep an eye on Cell to Cure ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 13, 2022, Martin Roland Jensen has joined the board of directors of Cell to Cure ApS.
As of December 13, 2022, Annette Ekblond has joined the board of directors of Cell to Cure ApS.
As of December 13, 2022, Jens Kastrup has joined the board of directors of Cell to Cure ApS.
As of December 13, 2022, Mandana Haack-Sørensen has joined the board of directors of Cell to Cure ApS.
As of December 13, 2022, Jesper Kihl has joined the board of directors of Cell to Cure ApS.
As of March 11, 2022, Martin Roland Jensen is registered as director of Cell to Cure ApS.
About Cell to Cure ApS
Cell to Cure ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cell2Cure ApS. The management consists of Jens Kastrup, Annette Ekblond and Mandana Haack-Sørensen. The board consists of Anders Østergaard (chair), Annette Ekblond, Jens Kastrup and Mandana Haack-Sørensen. The company's owners include MEDIC ADVICE ApS, Endeavour Cells ApS and Ekblond.ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -3,076,475 and a net result of DKK -9,792,604. Equity in the 2025 report amounted to DKK -1,179,103.